Fate Therapeutics
FATE
#8996
Rank
NZ$0.21 B
Marketcap
NZ$1.82
Share price
-6.19%
Change (1 day)
15.18%
Change (1 year)

Market capitalization of Fate Therapeutics (FATE)

Market cap: NZ$0.21 Billion

As of March 2026 Fate Therapeutics has a market cap of NZ$0.21 Billion. This makes Fate Therapeutics the world's 8996th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Fate Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.21 B6.3%
2025NZ$0.19 B-38.74%
2024NZ$0.32 B-44.24%
2023NZ$0.58 B-62.24%
2022NZ$1.54 B-81.12%
2021NZ$8.18 B-25.6%
2020NZ$10.99 B399.63%
2019NZ$2.20 B77.84%
2018NZ$1.23 B173.24%
2017NZ$0.45 B201.98%
2016NZ$0.14 B6.06%
2015NZ$0.14 B7.08%
2014NZ$0.13 B-15.44%
2013NZ$0.15 B

End of Day market cap according to different sources

On Mar 18th, 2026 the market cap of Fate Therapeutics was reported to be:

NZ$0.22 Billion
by Nasdaq info icon info icon
NZ$0.21 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Becton Dickinson
BDX
NZ$98.39 B 46,371.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$3.09 B 1,361.89%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
NZ$9.52 B 4,400.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$22.53 B 10,544.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
NZ$19.32 B 9,027.90%๐Ÿ‡บ๐Ÿ‡ธ USA